Ultrasound enhanced immunotherapy for glioblastoma

The aim of this Sanofi CIFRE project is to study the potential synergistic interplay between ultrasound and the immune system in preclinical glioblastoma (GBM) model and develop innovative and practical focused ultrasound solutions for the treatment of GBM, in combination with existing immunotherapies. Our study will focus on optimization of the FUS treatment method and help better define its most effective use in combination with immunotherapy. In order to develop a translational model, we will work on a preclinical immunocompetent syngeneic GBM model established on rat after stereotactic injection of glioma cell lines into the brain.

PDF - 122.2 ko

Haut de page